Cite
HARVARD Citation
Moysidis, D. et al. (2023). Prescription Rates and Prognostic Implications of Optimally Targeted Guideline-Directed Medical Treatment in Heart Failure and Atrial Fibrillation: Insights From The MISOAC-AF Trial. Journal of cardiovascular pharmacology. 81 (3), pp. 203-211. [Online].